Free Trial

Cartesian Therapeutics (RNAC) Insider Trading & Ownership

Cartesian Therapeutics logo
$19.68
-0.12 (-0.61%)
(As of 11/1/2024 ET)

Cartesian Therapeutics (NASDAQ:RNAC) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
57.90%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$2.38 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get RNAC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cartesian Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

RNAC Insider Buying and Selling by Quarter

Cartesian Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/4/2024Timothy A SpringerDirectorBuy80,301$22.58$1,813,196.58  
10/2/2024Timothy A SpringerDirectorBuy5,514$17.38$95,833.32  
8/12/2024Timothy A SpringerDirectorBuy8,016$12.72$101,963.52  
3/18/2024Timothy A SpringerDirectorBuy634$18.00$11,412.00  
3/14/2024Timothy A SpringerDirectorBuy21,612$16.20$350,114.40  
3/11/2024Timothy A SpringerDirectorBuy40$19.50$780.00  
3/8/2024Timothy A SpringerDirectorBuy160$19.80$3,168.00  
2/6/2024Timothy A SpringerDirectorBuy26$19.50$507.00  
1/17/2024Timothy A SpringerDirectorBuy26$20.70$538.20  
(Data available from 1/1/2013 forward)

RNAC Insider Trading Activity - Frequently Asked Questions

The list of insiders at Cartesian Therapeutics includes Timothy A Springer. Learn more on insiders at RNAC.

57.90% of Cartesian Therapeutics stock is owned by insiders. Learn more on RNAC's insider holdings.

The following insider purchased RNAC shares in the last 24 months: Timothy A Springer ($2,377,513.02).

Insiders have purchased a total of 116,329 RNAC shares in the last 24 months for a total of $2,377,513.02 bought.

Cartesian Therapeutics Key Executives

  • Dr. Carsten Brunn Ph.D. (Age 53)
    President, CEO & Director
    Compensation: $4.67M
  • Mr. Blaine T. Davis (Age 50)
    Chief Financial Officer
    Compensation: $2.49M
  • Dr. Metin Kurtoglu M.D. (Age 45)
    Ph.D., Chief Technology Officer
    Compensation: $398.28k
  • Dr. Chris Jewell Ph.D. (Age 42)
    Chief Scientific Officer
    Compensation: $296.85k
  • Mr. Matthew Bartholomae J.D.
    General Counsel & Secretary
  • Dr. Milos Miljkovic M.D. (Age 40)
    Ph.D., Chief Medical Officer
  • Dr. Emily English Ph.D. (Age 44)
    SVP & Head of Manufacturing
  • Mr. Yi Zhang Ph.D.
    Senior Director of Technology


This page (NASDAQ:RNAC) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners